Malene Watzinger

Malene Watzinger has over 15 years of work experience in the field of preclinical safety. Malene began their career in 2006 as a Study Director in Genetic Toxicology at the Institut Pasteur de Lille. In 2008, they moved to Citoxlab where they served as a Study Director in General Toxicology. From 2012 to 2023, they worked at Galapagos as a Preclinical Safety Leader. In 2023, they joined Agomab Therapeutics as the Head of Preclinical Safety.

Malene Watzinger obtained a Doctor of Pharmacy degree from Université Paris 5 in 2005.